Typhoon Rai (Odette) assessment in the Philippines
On 15 December 2021, typhoon Rai (locally known as Odette) formed, category 5, and after first landfall weakened to categories 4 & 3.
天灾
Ethiopia
Maria, Tedros and Yohannes, always in our memory
Today marks six months since the brutal murder of our colleagues Maria, Tedros and Yohannes, who were providing much-needed assistance to people in Ti...
武装冲突
Pakistan
Pakistan: Supporting COVID-19 vaccination activities in Karachi
Tucked away down a dusty side street in Karachi, Pakistan, is the rural health centre of Sher Shah where Doctors Without Borders / Medecins Sans Front...
新冠肺炎
新冠疫苗
疫苗接种
Lebanon
North Lebanon: Doctors Without Borders Starts COVID-19 Vaccination in Remote Areas
Doctors Without Borders / Médecins Sans Frontières (MSF) is contributing to Lebanon’s vaccination efforts in the remote areas of Wadi Khaled, and Khat...
新冠肺炎
新冠疫苗
疫苗接种
Myanmar
Myanmar: Political turmoil threatens HIV care
After the military seized power from Myanmar’s democratically elected government on 1 February 2021, doctors and nurses were among the first to lead t...
HIV/爱滋病
The father who faced the sea so his sons might go to school
Central Mediterranean - Ali*, 7 years old, rushes to hold his father’s hand as soon as the Doctors Without Borders / Médecins Sans Frontières (MSF) re...
搜救
South Sudan
South Sudan: Severe floods and lacklustre humanitarian response leave people dangerously exposed in Bentiu
People in Bentiu in northern South Sudan are facing outbreaks to infectious and waterborne diseases, increased food insecurity and malnutrition, due t...
Syria
Northwest Syria: The displaced population dreading another tough winter
Every year, Doctors Without Borders witnesses the direct health impact of winter through its activities in the camps. People living in camps face the ...
武装冲突
Doctors Without Borders response to license between Pfizer and Medicines Patent Pool for new COVID-19 treatment Paxlovid
Pfizer recently shared positive interim results for its COVID-19 oral antiviral investigational candidate PF-07321332 in combination with ritonavir (P...
